These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 5806435)

  • 1. Clinical and laboratory studies on the action of desferrioxamine.
    Cumming RL; Millar JA; Smith JA; Goldberg A
    Br J Haematol; 1969 Sep; 17(3):257-63. PubMed ID: 5806435
    [No Abstract]   [Full Text] [Related]  

  • 2. Evaluation of storage iron by chelates.
    Harker LA; Funk DD; Finch CA
    Am J Med; 1968 Jul; 45(1):105-15. PubMed ID: 5658862
    [No Abstract]   [Full Text] [Related]  

  • 3. The role of ascorbic acid in the turnover of storage iron.
    Roeser HP
    Semin Hematol; 1983 Apr; 20(2):91-100. PubMed ID: 6410511
    [No Abstract]   [Full Text] [Related]  

  • 4. [Influence of chelating agents on the distribution and excretion of radioiron in rats].
    Günther R
    Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1969; 262(4):405-18. PubMed ID: 4238109
    [No Abstract]   [Full Text] [Related]  

  • 5. Recent advances in iron metabolism.
    Powell LW; Halliday JW; Bassett ML
    Aust N Z J Med; 1979 Oct; 9(5):578-83. PubMed ID: 294916
    [No Abstract]   [Full Text] [Related]  

  • 6. Site of action of desferrioxamine in removing iron in normal and pathological conditions.
    Bobeck-Rutsaert MM; op den Kelder AM; Wiltink WF; van Eijk HG; Leijnse B
    Acta Haematol; 1974; 51(3):151-8. PubMed ID: 4218430
    [No Abstract]   [Full Text] [Related]  

  • 7. Iron and isoferritins in iron overload.
    Wagstaff M; Worwood M; Jacobs A
    Clin Sci (Lond); 1982 May; 62(5):529-40. PubMed ID: 7075150
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Disorders of iron metabolism in liver patients].
    Stromeyer G
    Internist (Berl); 1966 Jan; 7(1):33-42. PubMed ID: 4861683
    [No Abstract]   [Full Text] [Related]  

  • 9. Human isoferritins in normal and disease states.
    Drysdale JW; Adelman TG; Arosio P; Casareale D; Fitzpatrick P; Harzard JT; Yokota M
    Semin Hematol; 1977 Jan; 14(1):71-88. PubMed ID: 188201
    [No Abstract]   [Full Text] [Related]  

  • 10. Alterations in tissue ferritins in iron storage disorders.
    Powell LW; McKeering LV; Halliday JW
    Gut; 1975 Nov; 16(11):909-12. PubMed ID: 1193419
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Iron chelation in thalassemia: mechanism of desferrioxamine action.
    Hershko C; Rachmilewitz EA
    Isr J Med Sci; 1978 Nov; 14(11):1111-5. PubMed ID: 750535
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Abnormality in tissue isoferritin distribution in idiopathic haemochromatosis.
    Powell LW; Alpert E; Isselbacher KJ; Drysdale JW
    Nature; 1974 Jul; 250(464):333-5. PubMed ID: 4850369
    [No Abstract]   [Full Text] [Related]  

  • 13. Hepatic iron clearance from serum in treated hemochromatosis.
    Batey RG; Pettit JE; Nicholas AW; Sherlock S; Hoffbrand AV
    Gastroenterology; 1978 Nov; 75(5):856-9. PubMed ID: 700326
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The inhibitory effect of vitamin E on desferrioxamine-induced iron excretion in rats.
    Hershko C; Rachmilewitz EA
    Proc Soc Exp Biol Med; 1976 Jun; 152(2):249-52. PubMed ID: 935189
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Contribution to the study of intestinal absorption of inorganic and dietary iron by means of Fe59 in healthy subjects, patients with hemochromatosis and cirrhosis, before and after treatment with Desferal].
    Delaloye B; Magnenat P; Blanc B
    Nucl Med (Stuttg); 1967; ():97-111. PubMed ID: 5601765
    [No Abstract]   [Full Text] [Related]  

  • 16. Iron overload disorders: natural history, pathogenesis, diagnosis, and therapy.
    McLaren GD; Muir WA; Kellermeyer RW
    Crit Rev Clin Lab Sci; 1983; 19(3):205-66. PubMed ID: 6373141
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effective treatment of hereditary haemochromatosis with desferrioxamine in selected cases.
    Nielsen P; Fischer R; Buggisch P; Janka-Schaub G
    Br J Haematol; 2003 Dec; 123(5):952-3. PubMed ID: 14632789
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hemochromatosis: 1980 update.
    Powell LW; Bassett ML; Halliday JW
    Gastroenterology; 1980 Feb; 78(2):374-81. PubMed ID: 6985597
    [No Abstract]   [Full Text] [Related]  

  • 19. Biochemical studies of the iron cores and polypeptide shells of haemosiderin isolated from patients with primary or secondary haemochromatosis.
    Ward RJ; O'Connell MJ; Dickson DP; Reid NM; Wade VJ; Mann S; Bomford A; Peters TJ
    Biochim Biophys Acta; 1989 Oct; 993(1):131-3. PubMed ID: 2804120
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Heterogeneity of ferritin; contents of iron poor and iron rich ferritin in animal tissues].
    Shimada S; Sawai T; Wakayama T; Yoshioka M; Furuuchi I
    Nihon Ika Daigaku Zasshi; 1970 Apr; 37(2):121-5. PubMed ID: 5457089
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.